Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(40.0%)
Phase 3
2(40.0%)
Phase 4
1(20.0%)
5Total
N/A(2)
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07468994Not ApplicableCompleted

Effect of the MindUP Program on Depression, Anxiety, and Stress in Pakistani Orphan Adolescents

Role: lead

NCT04976413Not ApplicableUnknown

Efficacy of EMDR in the Treatment of Depression and Comorbid Anxiety

Role: lead

NCT04870021Phase 4Completed

Hepatitis B Birth Dose for Newborns

Role: lead

NCT03771326Phase 3Completed

KP-10 and Insulin Secretion in Men

Role: lead

NCT03315325Phase 3Completed

Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men

Role: lead

All 5 trials loaded